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The Unfolded Protein Response Is Activated in
Differentiating Epidermal Keratinocytes
Kazumitsu Sugiura1, Yoshinao Muro1, Kyoko Futamura1,2, Kenji Matsumoto2, Noriko Hashimoto2,
Yuji Nishizawa3, Tetsuro Nagasaka4, Hirohisa Saito2, Yasushi Tomita1 and Jiro Usukura5
The unfolded protein response (UPR), which is induced by stress to the endoplasmic reticulum (ER), is involved
in the functional alteration of certain cells, such as the differentiation of B cells to plasma cells. The aim of this
study is to determine whether the UPR is activated during epidermal keratinocyte (KC) differentiation. Here, we
show that the expression of the UPR-induced proteins Bip/GRP78 and HRD1 was increased in cells in the supra-
basal layers of normal human epidermis that contain KCs undergoing differentiation as well as in skin-
equivalent cultured KCs. However, Bip/GRP78 and HRD1 were poorly expressed in proliferating KCs in
squamous cell carcinoma and psoriasis vulgaris tissues. The epidermal growth factor receptor tyrosine kinase
inhibitor, PD153035, which induces KC differentiation, upregulated UPR-induced marker mRNAs and proteins.
Furthermore, microarray analyses and quantitative PCR revealed that ER stress-inducing reagents, tunicamycin
(TU), thapsigargin, and brefeldin A, altered the expression of genes essential for human epidermal KC
differentiation, including C/EBPb, KLF4, and ABCA12 in vitro. However, ABCA12 and KLF4 mRNA did not increase
with TU treatment after siRNA-mediated knockdown of XBP-1. Taken together, our findings strongly suggest that
the UPR is activated during normal epidermal KC differentiation and induces C/EBPb, KLF4, and ABCA12 mRNAs.
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INTRODUCTION
Translocation of newly synthesized peptides across the
endoplasmic reticulum (ER) membrane and their subsequent
folding, maturation, and transport rely on an elegant signaling
system called the unfolded protein response (UPR) (Schro¨der,
2008). The UPR facilitates the differentiation of B cells into
plasma cells (Iwakoshi et al., 2003), is involved in myogen-
esis (Nakanishi et al., 2005), and occurs at activated levels in
secretory-specific pancreatic b cells (Iwawaki et al., 2004).
The UPR activates transcription factors, including ATF6, XBP-1,
and ATF4, which induce a number of genes with correspond-
ing cis-elements, including Bip/GRP78, HRD1, PDI, and
CHOP/GADD153 (Schro¨der, 2008). Bip/GRP78 is a member
of the heat-shock protein-70 family and is involved in folding
and assembling proteins in the ER (Sommer and Jarosch,
2002). HRD1 is an ER ubiquitin ligase that works simulta-
neously with ER-associated degradation (Kikkert et al., 2004).
PDI catalyzes protein-disulfide reactions in the ER (Noiva
et al., 1991). CHOP/GADD153 is a member of the C/EBP
transcription factor family (Anand et al., 2005). All of these
proteins are induced by the UPR following ER stress (Figure 1)
and were used as UPR-induced markers in this study. There
are three major UPR pathways: IRE1-XBP-1, ATF6, and PERK-
eIF2a (Schro¨der, 2008) (Figure 1). Bip/GRP78 is primarily
regulated by ATF6 (Baumeister et al., 2005), HRD1 is
primarily regulated by XBP-1 (Yamamoto et al., 2008), and
CHOP/GADD153 is primarily regulated by ATF4, which is a
transcription factor downstream of PERK-eIF2a (Ma et al.,
2002), and ATF6; the regulation of PDI has not been precisely
identified.
The human epidermis is an epithelium that undergoes
constant turnover. This self-renewal process requires a certain
level of keratinocyte (KC) proliferation that is mostly
restricted to the basal layer of the epidermis (Barrandon and
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Green, 1987; Fuchs and Segre, 2000; Watt and Hogan,
2000). When KCs leave the basal layer, they migrate through
the upper layers, where they undergo morphological and
biochemical changes toward terminal differentiation. All of
these biochemical and morphological changes occur be-
cause of the upregulation and downregulation of certain
genes (Eckert et al., 1997). The identification of differentially
expressed transcripts and proteins is currently under study
using large-scale techniques (Radoja et al., 2006). However,
our understanding of the mechanisms of normal KC
differentiation is still insufficient. Elucidating the mechanism
of normal epidermal KC differentiation is crucial for under-
standing a number of skin diseases with abnormal epidermal
KC differentiation, including squamous cell carcinoma (SCC)
and psoriasis vulgaris (PV).
We reported earlier that Bip/GRP78 was diffusely distrib-
uted in cells from the supra-basal layer to the stratum corneum,
but was less present in cells of the basal layer (Sugiura et al.,
2007). Thus, we hypothesized that the UPR was activated in
the supra-basal layers in concert with epidermal KC differ-
entiation. Furthermore, if the UPR is significantly involved in
the normal differentiation of KCs, poor or aberrant activation of
the UPR could be linked to abnormal KC differentiation in skin
diseases. The aim of this study is to determine whether the
UPR is activated during normal differentiation of KCs and to
identify UPR-induced-genes in KCs.
To address these issues and to the best of our knowledge
we observed the expression of UPR-induced marker proteins
in normal human skin, SCC, PV, and skin equivalents by
immunocytochemistry, and assessed the mRNA levels for
UPR-induced marker genes in differentiating or proliferating
multilayered KCs by quantitative PCR (qPCR). Next, we
examined whether PD153035, an epidermal growth factor
receptor tyrosine kinase inhibitor (EGFR-TKI), induces UPR-
induced marker genes and proteins in KCs. Third, we used
microarray analyses to assess UPR-induced genes in KCs that
were treated with three types of UPR-inducing reagents. To
confirm the microarray results, three KC differentiation-
related genes, ABCA12, C/EBPb, and Kruppel-like factor 4
(KLF4), were analyzed by qPCR. To specify which of the three
main UPR branches regulates the expression of these three
genes, each branch of the UPR was inhibited with siRNA. In
this study, we show that the UPR is activated in differentiating
KCs compared with proliferating KCs. Moreover, we show
that the UPR induces ABCA12 and KLF4 through XBP-1 and
upregulates C/EBPb through ATF4 in KCs.
RESULTS
Immunocytochemistry of normal human tissues with antibodies
against Bip/GRP78, PDI, CHOP/GADD153, and HRD1
To identify KCs in the supra-basal layers relative to the basal
layers that had an activated UPR, we conducted immuno-
cytochemical studies on normal human skin using
antibodies against Bip/GRP78, HRD1, PDI, and CHOP/
GADD153.
Immunocytochemistry of thin epidermal sections showed
that Bip/GRP78, PDI, HRD1, and CHOP/GADD153 loca-
lized primarily to the cytoplasm. Under higher magnification,
cells of the basal layer had weak cytoplasmic staining for Bip/
GRP78, PDI, HRD1, and CHOP/GADD153, whereas epi-
dermal cells in the supra-basal layers to the granular layers
had stronger cytoplasmic staining for the UPR-induced
marker proteins (Figure 2). These results suggest that the
UPR was activated in KCs in the supra-basal layers, in
contrast to cells in the basal layers of the normal human
epidermis. All of these results were observed in two separate
normal human epidermal tissue samples and three normal
epidermal tissues that were adjacent to the Bowen’s disease
lesion (data not shown).
Immunocytochemistry of SCC and PV with antibodies against
Bip/GRP78 and HRD1
To analyze activation of the UPR in atypical KCs, which
differentiate poorly, we conducted immunocytochemistry on
SCC tissues (n¼ 4) with anti-Bip/GRP78 and anti-HRD1
antibodies. In contrast to normal epidermal tissue within the
same sections that stained strongly with these antibodies and
showed the same staining pattern as normal human
epidermal tissue, atypical KCs in SCC sections stained poorly
with these antibodies in all four-tissue samples. Figure 3c–f
shows a typical tissue specimen observed in this experiment.
Accumulation of unfolded protein
ER stress
Bip/GRP78
Unfolded protein
Golgi
ER
ATF6IRE1PERK
ERAD
UPR
elF2αTranslation
attenuation
ATF4
XBP1
XBP1 mRNA
ATF6(p50)
CRE ERSE
Nucleus UPR gene
Bip/GRP78
HRD1
CHOP
PD1
SP1 SP2
Figure 1. Signal transduction pathways of the unfolded protein response.
Perturbations in the efficiency of protein folding result in the accumulation of
unfolded or misfolded proteins in the ER. For example, physiological or
pharmacological conditions, including the disturbance of calcium
homeostasis, expression of mutated proteins, or ischemic insults, induce the
accumulation of these proteins. In the ER, the chaperone Bip/GRP78
dissociates from the ER transmembrane proteins IRE1, PERK, and ATF6,
leading to its transactivation. IRE1 catalyzes the splicing of XBP1 mRNA.
Activated PERK kinase phosphorylates eIF2a, resulting in reduced protein
synthesis and the formation of stress granules containing stalled transcripts.
Phosphorylation of eIF2a promotes the translation of ATF4. Activated ATF6
translocates from the ER to the Golgi, where it is cleaved by two proteases,
SP1 and SP2. Mature remodeled XBP1, ATF4, and ATF6, which are now
activated cytosolic DNA-binding domains , translocate to the nucleus and
induce a gene expression program called the unfolded protein response
(UPR). UPR genes include Bip/GRP78, HRD1, CHOP/GADD153, and PDI.
ER-associated degradation, ER-associated degradation. CRE and ERSE indicate
cis-elements.
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We also observed weak Bip/GRP78 and HRD1 staining of
proliferating KCs in tissue sections of Bowen’s disease,
which is in situ SCC. In contrast, we observed strong
staining of these proteins in sections of normal epidermis
that were adjacent to the Bowen’s disease lesion (data not
shown).
PV is a chronic inflammatory skin disease that is
characterized by proliferating KCs. Immunocytochemistry
was performed on PV tissues (n¼ 3) with anti-Bip/GRP78 and
anti-HRD1 antibodies. Figure 3i and j shows representative
tissue specimens. Bip/GRP78 and HRD1 staining was weak
in most of the KCs in the epidermis, but was intense around
the granular layers in all three tissue samples. These results
reinforced the idea that unlike differentiating cells, undiffer-
entiated KCs had minimal activation of the UPR.
Immunocytochemistry on skin equivalents with antibodies
against UPR-induced proteins
The LabCyte EPI-Model system consists of normal human-
derived epidermal KCs cultured to form a multilayered,
highly differentiated model of the human epidermis. This
model is structurally similar to human epidermal tissue as
determined by hematoxylin and eosin staining of thin
sections (Figure 4a). However, the KC-differentiating markers
keratin K1 and keratin K10 increased in the upper layers
around the granular layers in this model (Figure 4b). In
addition, it appears that this model has more proliferating cell
layers than the normal human epidermis. When EPI-Model
samples were immunocytochemically examined with anti-
Bip/GRP78 and anti-HRD1 antibodies, the cytoplasm stain-
ing was stronger in the upper differentiating layers than in the
basal and lower proliferating layers (Figure 4c and d). These
data were consistent with the results from the normal human
epidermal tissues.
Figure 2. Immunocytochemistry of normal human epidermal tissue. Thin
sections of the epidermis were immunostained with (a) anti-Bip/GRP78, (b)
anti-HRD1, (c) anti-PDI, (d) anti-CHOP/GADD153, or (e) control preimmune
serum no. 6369. The inset portion of panels a and b are the magnified images
of panels f and g, respectively. All antigens were visualized with HRP. Arrows
indicate the basement membranes. Bar: (a–e), 50mm; (f and g), 10 mm.
SCC
Figure 3. Immunocytochemistry of epidermal carcinoma and psoriasis
vulgaris sections. Thin sections of SCC tissue were stained with (a)
hematoxylin and eosin, and (c) adjacent sections were immunostained with
anti-Bip/GRP78, (d) anti-HRD1, or (g) preimmune serum no. 6369. (b) Is a
magnified image of the inset portion of (a). (a, c, and d) As diagrammed in (h),
SCC tissue is on the left side of the specimen, whereas the normal epidermis is
on the right. (e and f) Magnified images of the left and right inset portions of
(c), respectively. Thin PV tissue sections were immunostained with (i) anti-
Bip/GRP78 or (j) anti-HRD1. Bars: (a, c, and d), 500 mm; (b) 100 mm, (e and f)
20mm, (g) 1mm, (i and j) 100mm.
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Comparison of CHOP/GADD153, Bip/GRP78, PDI, and
XBP-1(S) mRNAs between immature and mature skin
equivalents
To confirm that UPR-induced genes were induced in
differentiating KCs, we measured mRNA expression of UPR-
induced marker genes, including CHOP/GADD153, Bip/
GRP78, PDI, HRD1, and XBP-1 spliced form (XBP-1(S)) in
immature and mature skin-equivalent KCs using qPCR. We
prepared both 3- and 14-day multilayered cultured skin-
equivalent KCs (Figure 5a and b). The 3-day cultured KCs did
not contain keratohyalin granules, which indicate differen-
tiating cells, and the 14-day cultured KCs were a mixture of
both proliferating cells (on the bottom and lower layers) and
differentiating cells (in the middle and top layers). Indeed, the
KC-differentiating markers keratin K1 and keratin K10 were
increased 3- and 2-fold, respectively, in the 14-day cultured
KCs relative to the 3-day KCs (Figure 5c and d). Moreover,
other KC-differentiating markers filaggrin, involucrin, and
transglutaminase 1 were increased 27-, 6-, and 4-fold,
respectively, in the 14-day cultured KCs relative to the 3-
day KCs (data not shown). Similarly, CHOP/GADD153, Bip/
GRP78, PDI, and XBP-1(S) mRNAs were increased approxi-
mately 2- to 3-fold in the 14-day cultured KCs compared with
the 3-day KCs (Figure 5e–h). Although HRD1 mRNA was
increased 1.3-fold in the 14-day cultured KCs compared with
the 3-day KCs, this difference was not statistically significant
(data not shown). Our results were compatible with an earlier
report that XBP-1(S) mRNA increases on activation of the
UPR (Yoshida et al., 2001).
PD153035 upregulated UPR-induced marker genes and
proteins
PD153035, an EGFR-TKI, is known to induce KC differentia-
tion in normal human epidermal KC (NHEK) cells in vitro
(Peus et al., 1997). We used this model to determine whether
PD153035 treatment increased the expression of UPR-
induced marker genes or proteins by qPCR and western
blotting. First, we confirmed that 10 mM PD153035 was not
toxic to NHEK cells using an LDH release assay with a
cytotoxicity detection kit (data not shown). After treatment
with 10 mM PD153035 for 12, 24, and 48 hours, keratin K1
and keratin K10 mRNAs increased 1.5-, 7-, and 26-fold, and
2, 8, and 25-fold, respectively (Figure 6a and b). Under these
conditions, CHOP/GADD153, Bip/GRP78, PDI, and XBP-
1(S) mRNAs increased approximately 2 to 12-fold (Figure
6c–f). Moreover, Bip/GRP78 and PDI proteins increased in
NHEK cells after treatment with 10 mM PD153035 for
72 hours (Figure 6g).
The UPR-induced ABCA12, C/EBPb, and KLF4 mRNAs in NHEK
cells
To screen the UPR-induced genes in normal epidermal KCs,
we performed microarray analyses in NHEK cells. We first
Figure 4. Immunocytochemistry of human skin equivalents. Thin sections of
LabCyte EPI-Model were stained with (a) hematoxylin and eosin and
immunostained with (b) anti-cytokeratin K1/K10, (c) anti-Bip/GRP78, (d) anti-
HRD1, or (e) preimmune serum no. 6369. Bar: 50 mm.
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Figure 5. qPCR of immature and mature skin -equivalent keratinocytes. Skin
equivalents (LabCyte EPI-Model) cultured for 3 (a) or 14 (b) days were
prepared (n¼ 4). Bar (b): 50 mm. Total RNAs were extracted from the cells and
reverse-transcribed. qPCR was performed for keratin K1, keratin K10, CHOP/
GADD153, Bip/GRP78, PDI, and XBP-1(S). The y axis of each graph indicates
the ratio of 3- or 14-day cultured KC mRNA divided by 3-day cultured KC
mRNA for (c) keratin K1, (d) keratin K10, (e) CHOP/GADD153, (f) Bip/
GRP78, (g) PDI, or (h) XBP-1(S). The quantity of mRNA examined was
normalized by dividing by the quantity of GAPDH in each sample. Note that
the y axis scales differ. (c–h) Error bars represent the SE. *Po0.05. **Po0.01.
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used microarray analysis to examine total RNAs in NHEK
cells cultured with or without 1 mgml1 of tunicamycin (TU)
for 6, 12, or 24 hours. TU inhibits bacterial and eukaryotic N-
acetylglucosamine, which induces the UPR. We found that
the expression of thousands of genes was changed dramati-
cally at 24 hours relative to 6 or 12 hours (data not shown).
Thus, we conducted a second microarray experiment with
total RNAs obtained from NHEK cells cultured with or
without 1 mM thapsigargin (TG) or 50 ngml1 of brefeldin A
(BFA) for 24 hours. TG is a high affinity inhibitor of a class of
enzymes, called sarco/endoplasmic reticulum Ca2þ ATPases
that induce the UPR. BFA inhibits ER/Golgi vesicular
traffic, causing an accumulation of peroxisomal matrix and
membrane proteins in the ER and subsequent induction
of the UPR.
To screen differentially expressed genes, we selected
genes with normalized values that changed at least 2-fold
after treatment with different UPR-inducing reagents and the
detection call ‘‘present’’ in at least one of the compared
groups. We identified 1,237 genes (541 upregulated and 696
downregulated) that were differentially regulated by any of
the UPR-inducing reagents (Figure 7). Some of the UPR-
induced genes, including CHOP/GADD153 and Bip/GRP78,
were increased twofold, which confirmed that the UPR was
activated in these experiments (data not shown).
To confirm our microarray analysis results, we incubated
NHEK cells with one of the three UPR-inducing reagents and
used qPCR to measure changes in the mRNA levels of three
selected genes. Treatment with 1 mgml1 of TU for 6, 12, and
24 hours increased the mRNA levels of ATP-binding cassette,
subfamily A, member 12 (ABCA12), C/EBPb, and KLF4 genes
(Figure 8a–c). ABCA12 is similar to an epidermal KC lipid
transporter, and defective ABCA12 results in the loss of the
skin’s lipid barrier and leads to harlequin ichthyosis, which is
the most severe and lethal form of recessive congenital
ichthyosis (Akiyama et al., 2005). C/EBPb is a transcription
factor that modifies differentiating KC-specific keratin K1 and
K10 (Zhu et al., 1999). KLF4 is highly expressed in
differentiating layers of the epidermis, which is both
necessary and selective for barrier acquisition (Segre et al.,
1999). We also observed that the above three genes were
upregulated after treatment with 1 mM TG or 50 ngml1 BFA
for 24 hours using qPCR (Figure 8d–f).
ABCA12, C/EBPb, and KLF4 mRNAs did not increase after
RNAi-mediated inhibition of one of the three main UPR
branches in HaCaT cells
To ascertain which signal transduction pathway of the UPR
regulates ABCA12, C/EBPb, and KLF4 mRNAs, we incubated
HaCaT cells with or without TU for 24 hours after RNA
interference (RNAi)-mediated depletion of ATF4, ATF6, XBP-
1, or CD4 as a negative control and used qPCR to measure
changes in the mRNA levels of these three genes. ATF4,
ATF6, and XBP-1 mRNAs were reduced by 10–20%
compared with the control after RNAi intervention with or
without TU treatment (Figure 9a–c). ABCA12 and KLF4
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Figure 6. qPCR and western blotting of PD153035-treated NHEK cells.
NHEK cells were incubated with 10mM PD153035 or DMSO (vehicle) for (a–f)
the indicated times or (g) 72 hours. Total RNAs were extracted from the cells
and reverse transcribed. qPCR was performed for keratin K1, keratin K10,
CHOP/GADD153, Bip/GRP78, PDI, and XBP-1(S). The y axis of each graph
indicates the ratio of PD153035 -treated or DMSO -treated KC mRNA divided
by DMSO -treated KC mRNA for (a) keratin K1, (b) keratin K10, (c) CHOP/
GADD153, (d) Bip/GRP78, (e) PDI, or (f) XBP-1(S). The mRNA levels were
normalized by dividing by the quantity of GAPDH in each sample. Note that
the y axis scales differ. (a–f) The error bars represent the SE. The experiments
were repeated four times. NHEK cell lysates were analyzed by western
blotting for PDI, Bip/GRP78, and b-actin, which served as a protein loading
control. The data are representative of four independent experiments. NS: not
significant, **Po0.01.
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Figure 7. Microarray analyses of differentially expressed genes after treating
with UPR-inducing reagents. NHEK cells were incubated for 24 hours with
1mgml1 TU or DMSO, 1 mM TG or DMSO, or 50 ngml1 BFA or ethanol.
Total RNA was extracted for microarray analysis. These diagrams show the
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with the respective vehicle control for each reagent.
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mRNAs did not increase with TU treatment and RNAi-
mediated deletion of XBP-1 (Figure 9d and f). In addition, C/
EBPb mRNA did not increase after TU treatment and RNAi-
mediated deletion of ATF4 (Figure 9e).
DISCUSSION
The epidermis is a self-renewing stratified epithelium
populated primarily by KCs that undergo a complex and
dynamic program of terminal differentiation throughout life
(Fuchs, 1990). This process begins when proliferating KCs of
the basal layers stop dividing and begin migrating succes-
sively through the spinous, granular, and cornified cell layers
(Eckert, 1989; Fuchs, 1990). The ability of KCs to differentiate
is regulated by a number of biological signals derived from
cell–cell or cell–matrix interactions that act downstream of
various signaling pathways (Szabowski et al., 2000). The
pathways that are particularly important for regulating KC
growth and differentiation include p63, IKKa, NF-kB, Notch,
C/EBPb, KLF4, and EGFR-TK (Seitz et al., 1998; Hu et al.,
1999; Segre et al., 1999; Zhu et al., 1999; Rangarajan et al.,
2001; Koster et al., 2004; Ferby et al., 2006).
In our first series of experiments, we showed that the UPR
activation markers Bip/GRP78, HRD1, PDI, and CHOP/
GADD153 were induced in the supra-basal layers of the
epidermis. Moreover, in undifferentiated, atypical KCs of SCC
and PV tissues, Bip/GRP78 and HRD1 were expressed at
lower levels than in normal differentiating KCs. In normal
human skin equivalents, these two antigens were upregulated
in the upper layers, and there were higher mRNA levels of
CHOP/GADD153, Bip/GRP78, PDI, and XBP-1(S) in 14-day-
multilayer cultured KCs than in 3-day cultured KCs.
Furthermore, in PD153035-treated KCs, a model of KC
differentiation, CHOP/GADD153, Bip/GRP78, PDI, and
XBP-1(S) were increased. Thus, we conclude that the
UPR is activated in differentiating KCs compared with
proliferating KCs.
In the next series of experiments, we used qPCR to show
that UPR-activating reagents TU, TG, and BFA-induced KC
differentiation-related molecules, including ABCA12, C/
EBPb, and KLF4, and that the induction of these molecules
was inhibited by knocking down ATF4 or XBP-1 expression
with RNAi in HaCaT cells.
Two EGFR-TKIs, gefitinib, and erlotinib, have been shown
to induce GADD153/CHOP (Wang et al., 2008), and our
observation that PD153035 induces ER stress in KCs is
consistent with this report. However, whether these EGFR-
TKIs induce ER stress by inhibiting EGFR-TK is still
undetermined. C/EBPb mRNA is induced during ER stress
through ATF4 (Chen et al., 2005), and our results are
consistent with this report. ABCA12 and KLF4 mRNAs are
regulated by peroxisome proliferator-activated receptor g
agonists through an unclarified signal transduction pathway
and through a peroxisome proliferator-activated receptor
g-independent pathway, respectively (Chen and Tseng, 2005;
Jiang et al., 2008). In addition, peroxisome proliferator-
activated receptor g agonists, also known as KC differentia-
tion stimulants, activate the UPR (Mao-Qiang et al., 2004;
Weber et al., 2004). Therefore, our findings that the UPR
induces ABCA12 and KLF4 mRNA levels possibly through
XBP-1 are potentially consistent with earlier reports on
mRNA regulation by peroxisome proliferator-activated re-
ceptor g agonists.
The role of the UPR in B-cell differentiation has been
investigated extensively (Iwakoshi et al., 2003). XBP-1, a
transcription factor induced by ER stress, plays a large role of
the differentiation of B cells into plasma cells. For the first
time, we have shown that the UPR is involved in the
expression of epidermal KC differentiation-related genes. This
finding supports an approach, which to our knowledge was
previously unreported, for studying a number of skin diseases
with abnormal epidermal KC differentiation. In fact, Anand
et al. (2005) reported that UVA- and UVB-induced apoptosis
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Figure 8. qPCR of ABCA12, C/EBPb, and KLF4 in NHEK cells after TU, TG, or BFA treatment. NHEK cells were incubated with 1 mgml1 TU or DMSO
(vehicle) for the indicated times (a–c). The y axis of each graph indicates the ratio of TU-treated mRNAs (filled boxes) or DMSO-treated mRNAs (open boxes)
divided by the DMSO-treated mRNAs of (a) ABCA12, (b) C/EBPb, and (c) KLF4. (d–f) NHEK cells were incubated with 1 mM TG or DMSO (vehicle), and 50 ng
BFA or ethanol (vehicle) for 24 hours. The y axis of each graph indicates the ratio of TG- or BFA-treated mRNAs (filled boxes) or the vehicle-treated mRNAs (open
boxes) divided by the vehicle-treated mRNAs of (d) ABCA12, (e) C/EBPb, and (f) KLF4. The mRNA levels were normalized by dividing by the quantity of GAPDH
in each sample. The experiments were repeated four times. Note that the y axis scales differ. Error bars represent the SE. *Po0.05. **Po0.01.
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of KCs in vivo (UVA and UVB skin damage) is mediated
through the UPR . Moreover, our findings suggest that KCs in
the epidermis are an appropriate research model for studying
the UPR in vivo.
Plasma cells, pancreatic cells, alveolar type II cells, and
hepatocytes cope with the UPR to secrete specific secretory
proteins (Iwakoshi et al., 2003; Iwawaki et al., 2004; Zhang
et al., 2006; Mimura et al., 2007). KCs in the granular layers
possess lamellar granules, and components of these granules
are secreted before these cells terminally differentiate into
cornified cells. In that KCs differentiate into secretory cells, it
is reasonable to conclude that the UPR is partially involved in
epidermal KC differentiation.
A better understanding of the epidermal UPR will help
develop therapies for many skin diseases that are associated
with abnormal epidermal KC differentiation and further our
understanding of skin disorders themselves. In addition, UPR-
inducing agents might be useful to treat disorders with altered
epidermal differentiation. For example, we showed that SCC
tissues have poor activation of the UPR, and Fribley et al. (2006)
reported that the proteasome inhibitor PS-341 induces apopto-
sis by activating a branch of the UPR, the PERK-ATF4 pathway
in head and neck SCCs. We also showed poor activation of the
UPR in KCs of PV, a common skin disease featuring abnormal
epidermal KC differentiation. Thus, appropriate regulation of
the UPR in KCs may also provide a therapeutic target for PV.
Consequently, we believe that the epidermal UPR is crucial for
treating skin diseases as well as controlling differentiation -
related genes of normal epidermal KCs.
MATERIALS AND METHODS
Human skin tissues
Normal human skin was obtained from the scalp of a 16-year-old
patient with a benign scalp tumor and from the left anterior arm of a
37-year-old healthy individual. Skin cancer tissues were obtained
from four patients with SCC (mean age 90 years; range 84–97 years)
and three patients with Bowen’s disease (mean age 72 years; range
68–80 years). Skin tissues with benign proliferating KCs were
obtained from three patients with psoriasis vulgaris (mean age 51
years; range 42–64 years). All skin tissue samples were obtained after
obtaining written informed consent (Okamoto et al., 2004). The use
of human materials was approved by the Ethics Committee of
Nagoya University, Graduate School of Medicine. The study was
conducted according to the principles of the Declaration of Helsinki.
Antibodies and reagents
The following polyclonal antibodies were purchased from commer-
cial sources: anti-Bip/GRP78, anti-PDI, anti-CHOP/GADD153
(Santa Cruz Biotechnology, Santa Cruz, CA), anti-HRD1 (Abgent,
San Diego, CA), anti-cytokeratin 1/10 (Millipore, Bedford, MA), and
anti-b-actin (Sigma Aldrich, St Louis, MS). TU, TG, BFA, and
PD150305 were purchased from Sigma Aldrich. The sequences of
the Taqman probes for real-time quantitative PCR are shown in
Table 1. Three TaqMan Probes for filaggrin, transglutaminase 1, and
involucrin were purchased from TaqMan Gene Expression Assays
provided by Applied Biosystems (Foster City, CA). SiRNA sequences
for ATF4, ATF6, XBP-1, and CD4 are summarized in Table 2.
Immunocytochemistry
Immunocytochemistry on human skin or LabCyte EPI-Model (J-Tec,
Gamagori, Japan), a normal human epidermal tissue model, was
performed as described with slight modifications (Sugiura et al.,
2007). The Vectastain Elite ABC-PO (rabbit IgG) kit (Vector
Laboratories, Burlingame, CA) was used for staining. Thin sections
(6mm) were cut from samples embedded in paraffin blocks. The
sections were immersed in a 0.4% pepsin solution for 30minutes
and soaked for 20minutes at room temperature in 0.3% H2O2/
methanol to block endogenous peroxidase activity. After washing in
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Figure 9. Effect of ATF4, ATF6, and XBP1 disruption on ABCA12, C/EBPb, and KLF4 gene expression in HaCaT cells. HaCaT cells were transfected with siRNA
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phosphate-buffered saline (PBS) with 0.01% Triton X-100, the
sections were incubated for 30minutes in PBS with 4% BSA
followed by an overnight incubation at 41C with the primary
antibodies (10 ngml1) in PBS containing 1% BSA. After washing in
PBS buffer, the thin sections were stained with avidin-conjugated
goat anti-rabbit immunoglobulin secondary antibodies for 1 hour at
room temperature and washed in PBS. After washing, the tissue
sections were immersed in Vectastain Elite ABC Reagent for
30minutes and then washed in PBS. The antibody complexes were
visualized by adding 1% H2O2. Rabbit pre-immune serum (pre-
immune no. 6369) (Sugiura et al., 2007) corresponding to 10 ngml1
was used as a negative control.
Real -time qPCR
The KC cell line HaCaT was kindly provided by Dr N. Fusenig
(German Cancer Research Center, Heidelberg, Germany) (Boukamp
et al., 1988). NHEK cells derived from neonatal foreskin were
purchased from Kurabo (Kurashiki, Japan). LabCyte EPI-Model cells
cultured for 3 or 14 days were purchased from J-Tec. HaCaT cells or
NHEK cells were seeded at 10,000 cells per cm2 and cultured in
DMEM containing 1.8mM calcium supplemented with 10% fetal calf
serum or in Epilife KG2 (Kurabo, Osaka, Japan) at 371C with 5%
CO2. When cells reached 60% confluency, they were cultured in the
presence or absence of 10 mM PD153035 (EGFR-TKI) , 1 mgml1 TU,
1mM TG, or 50 ngml1 BFA (UPR-inducing reagents). Total RNA was
extracted from the cells at different time points using an RNeasy Mini
kit (Qiagen, Valencia, CA) according to the manufacturer’s instruc-
tions. cDNA was synthesized from 250 ng of total RNA using a
random primer procedure and the Takara RNA PCR kit ver. 3.0
(Takara Bio, Otsu, Japan) according to the manufacturer’s instruc-
tions. Real-time qPCR was performed using a Sequence Detector
System (ABI Prism 5700 Sequence Detection System and software;
PerkinElmer Life Sciences, Wellesley, MA; or Mx3000P Real-Time
PCR System and software; Stratagene, La Jolla, CA). Amplification
was performed in a final volume of 25ml that contained 20 ng of
cDNA from the reverse transcription reaction, the primers and
TaqMan Probes, and 12.5ml TaqMan Universal PCR Master Mix
(Roche, Branchburg, NJ). The gene expression values were normal-
ized to GAPDH to correct for minor variations in mRNA extraction
and reverse transcription. Each experiment was performed three or
four times.
LDH release assay
The LDH release assay was performed with the cytotoxicity
detection kit, PLUS (LDH) (Roche) according to the manufacturer’s
instructions. Briefly, 7,000 NHEK cells per well were incubated
in 96-well plates overnight. Cells were cultured in the
presence or absence of 10 mM PD153035 for 24 hours. An
ELISA reader (Multiskan JX; Thermo Labosystem, Vantaa, Finland)
was used to measure absorbance at 492 nm, which reflected the
LDH activity.
Western blotting of NHEK cell extracts
Cell lysates were separated by 12.5% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and transferred to polyvinylidene
difluoride membranes (Millipore, Bedford, MA) as described
Table 2. RNA sequences of the siRNA
Sense Anti Sense
CD4 acaaggaagugucuguaaaTT uuuacagacacuuccuuguTT
ATF4 ugacacuugugaucucuuuTT aaagagaucacaagugucaTT
ATF6 gcaaccaauuaucaguuuaTT uaaacugauaauugguugcTT
XBP-1 agugguagauuuagaagaaTT uucuucuaaaucuaccacuTT
Table 1. DNA sequences of the probes for the quantitative real time PCR
Forward Reverse Taqman
GRP78 CGGCCGCACGTGGA CAACCACCTTGAACGGCAA CCCGTCTGTGCAGCAGCAGGACATCAA
CHOP TGCAGATTCACCATTCGGTC AGGAAATCGAGCGCCTGAC CAGAGCTCGGCGAGTCGCCTCTACTT
PDI AGGGCAAGATCCTGTTCATCTTC CGGGCACTCTTCCTTCTTCAG CAGCGACCACACCGACAACCAAGCG
HRD1 GCTTTGTTGCACTCTTCACTCTTC GAGATGTTGGGGCTGCGTTC AGTCCACACGGTCCTCAGCCAGCC
XBP-1(S) ATGCCCTGGTTGCTGAAGAG GAGATGTTCTGGAGGGGTGAC CCTGCACCTGCTGCGGACTCAG
K1 ACAAGCCACACCACCATCAG CATAGCTGCTACCTCCAGAGC AGCCACCGCCGCCACCTCCT
K10 GGGGCAGTTTCGGAGGTG ACCAAAGCCTCCTCCAAAGC CTCCACCAAAGCCGCCTCCACCAAAG
ATF4 CATGGGTTCTCCAGCGACAAG TTGGAGGACTGACCAACCC CACAGGCAGCCATTCGGAGGAGCC
ATF6 TGTGGTACAACTTCAAGCACCTG CACTGGGCTATTCGCTGAAGG TCTGCCCTCTGCTCAGCCAGTCCT
XBP-1 TTGAGAACCAGGAGTTAAGACAGC GCCTCACTTCATTCCCCTTGG CCGCCTCCTCTTCAGCAACCAAGGG
ABCA12 CCACTTGGACGAGGCTGAAG AGGCTTCCTTGAGGTAAAATGGG TGAGTGACCGCATCGCCTTCCTGGA
C/EBPbeta AGGCCAAGAAGACCGTGGAC AGGACCTTGTGCTGCGTCTC CACAGCGACGAGTACAAGATCCGGCG
KLF4 TGGACCCGGTGTACATTCCG ACGCCTTCAGCACGAACTTG CAGCAGCCGCAGCCGCCAGG
GAPDH TGGGCTACACTGAGCACCAG CAGCGTCAAAGGTGGAGGAG TCTCCTCTGACTTCAACAGCGACACCC
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(Sugiura and Muro, 1999). Strips of membrane were incubated with
anti-Bip, anti-PDI, and b-actin antibodies at dilutions of 1:5,000,
1:5,000, and 1:20,000, respectively. The antibody-antigen com-
plexes were detected with horseradish peroxidase (HRP)-conjugated
goat anti-mouse or -rabbit IgG (Dako Co. Ltd, Glostrup, Denmark) at
1:1,000 dilutions followed by ECL western blotting substrate (GE
Healthcare Bio-Sciences, Little Chalfont, UK), as described by the
manufacturer.
Microarray analysis of gene expression
Microarray analysis was performed as described earlier (Saito et al.,
2006). Briefly, total RNA was extracted with an RNeasy kit (Qiagen).
(Total RNAs were pooled from three individual experiments for each
time point.) Three micrograms of total RNA from each sample (6, 12,
or 24 hours) were used to prepare cRNA. Gene expression was
analyzed with the GeneChip Human Genome U133 plus 2.0 Array
(Affymetrix, Santa Clara, CA), which contains 54,675 oligonucleo-
tide probe sets representing approximately 22,000 genes, according
to the manufacturer’s protocols (Expression Analysis Technical
Manual). Data analysis was performed using the GeneChip
Operation System (Affymetrix) and GeneSpring software ver. 7.2
(Silicon Genetics, San Carlos, CA). To normalize variations in the
staining intensity between chips, the average difference for all genes
on a given chip was divided by the median of all measurements on
that chip. Hierarchical clustering analysis was performed using a
minimum distance of 0.001, a separation ratio of 0.5, and the
standard definition of the correlation distance.
RNAi experiments
For RNAi experiments, HaCaT cells were transfected with 5 nM
siRNA for CD4, ATF4, ATF6, or XBP1 using HiPerFect transfection
reagent (Qiagen) according to the manufacturer’s protocol.
Statistical analysis
An unpaired t-test was used to analyze the real-time PCR studies.
Po0.05 was considered statistically significant.
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